First National Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,440
| Closed | -$2.54M | – | 223 |
|
|
2025
Q1 | $2.54M | Sell |
20,440
-310
| -1% | -$38.5K | 0.41% | 75 |
|
|
2024
Q4 | $2.56M | Sell |
20,750
-4,753
| -19% | -$585K | 0.41% | 76 |
|
|
2024
Q3 | $2.84M | Buy |
25,503
+632
| +3% | +$70.4K | 0.45% | 70 |
|
|
2024
Q2 | $2.65M | Buy |
24,871
+5,864
| +31% | +$626K | 0.49% | 63 |
|
|
2024
Q1 | $2.43M | Buy |
19,007
+1,975
| +12% | +$252K | 0.54% | 57 |
|
|
2023
Q4 | $2.09M | Buy |
17,032
+4,120
| +32% | +$507K | 0.6% | 56 |
|
|
2023
Q3 | $1.67M | Buy |
12,912
+5,372
| +71% | +$695K | 0.75% | 41 |
|
|
2023
Q2 | $935K | Buy |
7,540
+2,124
| +39% | +$263K | 0.86% | 38 |
|
|
2023
Q1 | $793K | Buy |
+5,416
| New | +$793K | 0.9% | 42 |
|